BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 21, 2015
View Archived Issues
An attenuated, gD-deleted vaccine provides 100% protection against herpes simplex virus
Read More
Dose-escalation to proceed in phase I/II trial of Vivolux's iron chelator for cancer
Read More
Anika Therapeutics completes enrollment in repeat-injection study of Cingal
Read More
Combined use of cfDNA and CareDx's AlloMap to identify rejection in heart transplant recipients
Read More
Takeda initiates collaboration on identification and analysis of RNA-binding proteins
Read More
Panther licenses rights to TDZD-8 from University of Rochester
Read More
BNC-210 enters phase II evaluation for anxiety
Read More
Expedited development of lonafarnib with ritonavir for hepatitis D virus infection
Read More
Lilly reports phase III trial success with ixekizumab
Read More
CiRA and Takeda to collaborate on drug discovery using iPS cells
Read More
Mallinckrodt seals the deal with Ikaria
Read More
Brain cancer collaboration between Novogen and the Feinstein Institute announced
Read More
Ampio reports results from phase III trial STRIDE of Ampion in OA
Read More
SAGE Therapeutics initiates phase III expanded access study of SAGE-547 in SRSE
Read More
Sumitomo Dainippon Pharma reports mGlu5 receptor modulators
Read More
Polish scientists develop mGlu4 PAMs
Read More
PPARalpha antagonists hold promise as a complement to chemotherapy for pancreatic cancer
Read More
Paclitaxel trevatide named orphan drug in the U.S.
Read More
ZV-0201, an ADC for the treatment of HER2-positive cancers
Read More
University of California, Oakland presents integrin alphavbeta1 antagonists for fibrosis
Read More
Potent ADAM 17 antibody inhibits tumor growth
Read More
Vertex develops inhibitors of PAR2 signaling pathway
Read More
MBX-8025 receives FDA orphan status for Frederickson Type I or V hyperlipoproteinemia
Read More
Tamoxifen found to inhibit the effects of amphetamine
Read More